首页> 外文OA文献 >Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization
【2h】

Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization

机译:scAAV2激活Rap 1a的视网膜色素上皮细胞表达抑制脉络膜新血管形成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To test the hypothesis that increased Rap1a activity specifically in retinal pigment epithelial cells resists choroidal neovascularization (CNV), self-complementary adeno-associated virus 2 (scAAV2) with RPE65-promoter-driven GFP vectors were generated and introduced subretinally into Rap1b-deficient mice. Six-week-old mice that received subretinal control (scAAV2-Con) or constitutively active Rap1a (scAAV2-CARap1a) showed strong GFP at the 5 × 10(8) viral particle/µl dose 5 weeks later without altering retinal morphology or function. Compared to scAAV2-Con- or phosphate-buffered saline (PBS)-injected, eyes injected with scAAV2-CARap1a had increased Rap1 in retinal pigment epithelial (RPE)/choroidal lysates and a significant reduction in CNV volume 7 days after laser, comparable to eyes that received intravitreal anti-VEGF versus IgG control. scAAV2-CARap1a-, but not anti-VEGF-, injected eyes had increased pan-cadherin in RPE/choroids. In cultured RPE cells, increased active Rap1a inhibited TNFα-induced disassociation of junctional pan-cadherin/β-catenin complexes, increased transepithelial electrical resistance through an interaction of β-catenin with phosphorylated scaffold protein, IQGAP1, and inhibited choroidal endothelial cell (CEC) transmigration of an RPE monolayer. This evidence shows that increased Rap1a activity specifically in RPE cells is sufficient to reduce CEC transmigration and CNV and involves IQGAP1-mediated protection of RPE junctional complexes.
机译:为了检验这一假说,即Rap1a活性在视网膜色素上皮细胞中的特异性增强抵抗脉络膜新生血管(CNV),生成了具有RPE65启动子驱动的GFP载体的自互补腺伴随病毒2(scAAV2),并将其视网膜下引入Rap1b缺陷型小鼠中。六周龄的小鼠接受视网膜下对照(scAAV2-Con)或组成性活性Rap1a(scAAV2-CARap1a),在5周×5×10 10(8)病毒颗粒/μl剂量下显示强GFP,而未改变视网膜的形态或功能。与注射scAAV2-Con或磷酸盐缓冲盐水(PBS)相比,注射scAAV2-CARap1a的眼睛在视网膜色素上皮(RPE)/脉络膜溶解物中的Rap1升高,并且激光治疗7天后CNV体积显着减少,与接受玻璃体内抗VEGF和IgG对照的眼睛。注射scAAV2-CARap1a-而不是抗VEGF-的眼睛在RPE /脉络膜中的泛钙黏着蛋白增加。在培养的RPE细胞中,活性Rap1a的增加会抑制TNFα诱导的连接泛钙粘蛋白/β-catenin复合物的解离,通过β-catenin与磷酸化支架蛋白IQGAP1的相互作用而增加跨上皮电阻,并抑制脉络膜内皮细胞(CEC) RPE单层的迁移。该证据表明,Rap1a活性在RPE细胞中的特异性增强足以减少CEC迁移和CNV,并涉及IQGAP1介导的RPE连接复合物的保护。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号